The unstoppable attraction for induced pluripotent stem cells: Are they the magic bullet for modeling inherited arrhythmogenic diseases?

Journal of the American College of Cardiology

Volumn 60, Issue 11, 2012, Pages 1001-1004

  Gnecchi, Massimiliano ^a,b   Schwartz, Peter J ^a,b,c,d,e  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

cardiomyocytes; catecholaminergic polymorphic ventricular tachycardia; human induced pluripotent stem cells; inherited arrhythmogenic diseases; long QT syndrome

Indexed keywords

ACTION POTENTIAL; ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL DIFFERENTIATION; GENE EXPRESSION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; MISSENSE MUTATION; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM;

EID: 84865737777     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.019     Document Type: Editorial

References (21)

1. I. Itzhaki, L. Maizels, I. Huber Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells J Am Coll Cardiol 60 2012 990 1000
2. K. Takahashi, S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
3. K. Takahashi, K. Tanabe, M. Ohnuki Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
4. J. Yu, M.A. Vodyanik, K. Smuga-Otto Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
5. K. Narsinh, K.H. Narsinh, J.C. Wu Derivation of human induced pluripotent stem cells for cardiovascular disease modeling Circ Res 108 2011 1146 1156
6. J. Zhang, G.F. Wilson, A.G. Soerens Functional cardiomyocytes derived from human induced pluripotent stem cells Circ Res 104 2009 e30 e41
7. J. Satin, I. Itzhaki, S. Rapoport Calcium handling in human embryonic stem cell-derived cardiomyocytes Stem Cells 26 2008 1961 1972
8. A. Moretti, M. Bellin, A. Welling Patient-specific induced pluripotent stem-cell models for long-QT syndrome N Engl J Med 363 2010 1397 1409
9. I. Itzhaki, L. Maizels, I. Huber Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
10. D. Malan, S. Friedrichs, B.K. Fleischmann, P. Sasse Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro Circ Res 109 2011 841 847
11. M. Yazawa, B. Hsueh, X. Jia Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome Nature 471 2011 230 234
12. A. Novak, L. Barad, N. Zeevi-Levin Cardiomyocytes generated from CPVT(D307H) patients are arrhythmogenic in response to beta-adrenergic stimulation J Cell Mol Med 16 2012 468 482
13. C.B. Jung, A. Moretti, M. Mederos y Schnitzler Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia EMBO Mol Med 4 2012 180 191
14. P.J. Schwartz, S.G. Priori, E.H. Locati Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate Implications for gene-specific therapy Circulation 92 1995 3381 3386
15. Q. Wang, J. Shen, I. Splawski SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome Cell 80 1995 805 811
16. M. Hayashi, I. Denjoy, F. Extramiana Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia Circulation 119 2009 2426 2434
17. P.J. Schwartz Cascades or waterfalls, the cataracts of genetic screening are being opened on clinical cardiology J Am Coll Cardiol 55 2010 2577 2579
18. L. Crotti, M.C. Monti, R. Insolia NOS1AP is a genetic modifier of the long-QT syndrome Circulation 120 2009 1657 1663
19. P.J. Schwartz, L. Crotti, R. Insolia Long QT syndrome: From genetics to management Circ Arrhythm Electrophysiol 5 2012 868 877
20. P.W. Burridge, G. Keller, J.D. Gold, J.C. Wu Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming Cell Stem Cell 10 2012 16 28
21. T. Zhou, C. Benda, S. Duzinger Generation of induced pluripotent stem cells from urine J Am Soc Nephrol 22 2011 1221 1228